C-type lectin-like proteins from snake venoms

Toxicon

Volumn 60, Issue 4, 2012, Pages 512-519

  Arlinghaus, Franziska T ^a   Eble, Johannes A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

C type lectin like proteins; Coagulation factor; Integrin; Rhodocetin

Indexed keywords

AGGRETIN; ALBOAGGREGIN B; BITISCETIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; BOTROCETIN; COLLAGEN; CONVULXIN; ECHICETIN; EMS 16; EMS16; FLAVOCETIN A; GLYCOPROTEIN IB; GLYCOPROTEIN VI; HETERODIMER; LECTIN; OLIGOMER; RHODOCETIN; SNAKE VENOM; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR; VP 12;

ALPHA CHAIN; ANTIANGIOGENIC ACTIVITY; ANTICOAGULATION; ARTICLE; BETA CHAIN; BLOOD CLOTTING; DRUG PROTEIN BINDING; HEMOSTASIS; HUMAN; INHIBITION KINETICS; METASTASIS INHIBITION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN SUBUNIT; SNAKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION; CROTALID VENOMS; INTEGRIN ALPHA2BETA1; LECTINS, C-TYPE; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; REPTILIAN PROTEINS; VIPERIDAE;

EID: 84863785496     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.03.001     Document Type: Article

References (75)

1. Andrews R.K., Booth W.J., Gorman J.J., Castaldi P.A., Berndt M.C. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989, 28:8317-8326.
2. Andrews R.K., Kroll M.H., Ward C.M., Rose J.W., Scarborough R.M., Smith A.I., Lopez J.A., Berndt M.C. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996, 35:12629-12639.
3. Arnaout M.A., Mahalingam B., Xiong J.P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 2005, 21:381-410.
4. Atoda H., Hyuga M., Morita T. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E. J. Biol. Chem. 1991, 266:14903-14911.
5. Atoda H., Ishikawa M., Mizuno H., Morita T. Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein. Biochemistry 1998, 37:17361-17370.
6. Atoda H., Ishikawa M., Yoshihara E., Sekiya F., Morita T. Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization. J. Biochem. 1995, 118:965-973.
7. Batuwangala T., Leduc M., Gibbins J.M., Bon C., Jones E.Y. Structure of the snake-venom toxin convulxin. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:46-53.
8. Bergmeier W., Bouvard D., Eble J.A., Mokhtari-Nejad R., Schulte V., Zirngibl H., Brakebusch C., Fassler R., Nieswandt B. Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. J. Biol. Chem. 2001, 276:25121-25126.
9. Bracht T., Figueiredo de Rezende F., Stetefeld J., Sorokin L.M., Eble J.A. Monoclonal antibodies reveal the alteration of the rhodocetin structure upon alpha2beta1 integrin binding. Biochem. J. 2011, 440:1-11.
10. Calvete J.J., Marcinkiewicz C., Monleon D., Esteve V., Celda B., Juarez P., Sanz L. Snake venom disintegrins: evolution of structure and function. Toxicon 2005, 45:1063-1074.
11. Chang C.H., Chung C.H., Hsu C.C., Huang T.Y., Huang T.F. A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation. J. Thromb. Haemost. 2010, 8:2563-2570.
12. Chen Y.L., Tsai I.H. Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster. Biochemistry 1996, 35:5264-5271.
13. Chung C.H., Au L.C., Huang T.F. Molecular cloning and sequence analysis of aggretin, a collagen-like platelet aggregation inducer. Biochem. Biophys. Res. Commun. 1999, 263:723-727.
14. Chung C.H., Lin K.T., Chang C.H., Peng H.C., Huang T.F. The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production. Br. J. Pharmacol. 2009, 156:846-856.
15. Chung C.H., Peng H.C., Huang T.F. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway. Biochem. Biophys. Res. Commun. 2001, 285:689-695.
16. Chung C.H., Wu W.B., Huang T.F. Aggretin, a snake venom-derived endothelial integrin alpha 2 beta 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 2004, 103:2105-2113.
17. Clemetson K.J. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon 2010, 56:1236-1246.
18. Clemetson K.J., Clemetson J.M. Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb. Haemost. 2008, 99:473-479.
19. Clemetson K.J., Lu Q., Clemetson J.M. Snake C-type lectin-like proteins and platelet receptors. Pathophysiol. Haemost. Thromb. 2005, 34:150-155.
20. Clemetson K.J., Navdaev A., Dormann D., Du X.Y., Clemetson J.M. Multifunctional snake C-type lectins affecting platelets. Haemostasis 2001, 31:148-154.
21. Eble J.A., Beermann B., Hinz H.J., Schmidt-Hederich A. alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J. Biol. Chem. 2001, 276:12274-12284.
22. Eble J.A., Niland S., Bracht T., Mormann M., Peter-Katalinic J., Pohlentz G., Stetefeld J. The alpha2beta1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule. FASEB J. 2009, 23:2917-2927.
23. Eble J.A., Niland S., Dennes A., Schmidt-Hederich A., Bruckner P., Brunner G. Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol. 2002, 21:547-558.
24. Eble J.A., Tuckwell D.S. The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem. J. 2003, 376:77-85.
25. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin alpha2beta1. Cell 2000, 101:47-56.
26. Francischetti I.M., Saliou B., Leduc M., Carlini C.R., Hatmi M., Randon J., Faili A., Bon C. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon 1997, 35:1217-1228.
27. Fukuda K., Doggett T.A., Bankston L.A., Cruz M.A., Diacovo T.G., Liddington R.C. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure 2002, 10:943-950.
28. Fukuda K., Mizuno H., Atoda H., Morita T. Crystallization and preliminary x-ray studies of flavocetin-A, a platelet glycoprotein Ib-binding protein from the habu snake venom. Acta Crystallogr. D Biol. Crystallogr. 1999, 55:1911-1913.
29. Fukuda K., Mizuno H., Atoda H., Morita T. Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers. Biochemistry 2000, 39:1915-1923.
30. Hamako J., Matsui T., Suzuki M., Ito M., Makita K., Fujimura Y., Ozeki Y., Titani K. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem. Biophys. Res. Commun. 1996, 226:273-279.
31. Hirotsu S., Mizuno H., Fukuda K., Qi M.C., Matsui T., Hamako J., Morita T., Titani K. Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer. Biochemistry 2001, 40:13592-13597.
32. Hooley E., Papagrigoriou E., Navdaev A., Pandey A.V., Clemetson J.M., Clemetson K.J., Emsley J. The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure. Biochemistry 2008, 47:7831-7837.
33. Horii K., Okuda D., Morita T., Mizuno H. Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry 2003, 42:12497-12502.
34. Horii K., Okuda D., Morita T., Mizuno H. Crystal structure of EMS16 in complex with the integrin alpha2-I domain. J. Mol. Biol. 2004, 341:519-527.
35. Huang T.F., Liu C.Z., Yang S.H. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J. 1995, 309(Pt 3):1021-1027.
36. Ishikawa M., Kumashiro M., Yamazaki Y., Atoda H., Morita T. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. J. Biochem. 2009, 145:123-128.
37. Jandrot-Perrus M., Lagrue A.H., Okuma M., Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1. J. Biol. Chem. 1997, 272:27035-27041.
38. Koh D.C., Armugam A., Jeyaseelan K. Snake venom components and their applications in biomedicine. Cell Mol. Life Sci. 2006, 63:3030-3041.
39. Kowalska M.A., Tan L., Holt J.C., Peng M., Karczewski J., Calvete J.J., Niewiarowski S. Alboaggregins A and B. Structure and interaction with human platelets. Thromb. Haemost. 1998, 79:609-613.
40. Leduc M., Bon C. Cloning of subunits of convulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom. Biochem. J. 1998, 333(Pt 2):389-393.
41. Li X., Zheng L., Kong C., Kolatkar P.R., Chung M.C. Purpureotin: a novel di-dimeric C-type lectin-like protein from Trimeresurus purpureomaculatus venom is stabilized by noncovalent interactions. Arch. Biochem. Biophys. 2004, 424:53-62.
42. Lu Q., Navdaev A., Clemetson J.M., Clemetson K.J. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis. Toxicon 2005, 45:1089-1098.
43. Maita N., Nishio K., Nishimoto E., Matsui T., Shikamoto Y., Morita T., Sadler J.E., Mizuno H. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins. J. Biol. Chem. 2003, 278:37777-37781.
44. Marcinkiewicz C., Lobb R.R., Marcinkiewicz M.M., Daniel J.L., Smith J.B., Dangelmaier C., Weinreb P.H., Beacham D.A., Niewiarowski S. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry 2000, 39:9859-9867.
45. Matsui T., Hamako J. Structure and function of snake venom toxins interacting with human von Willebrand factor. Toxicon 2005, 45:1075-1087.
46. Matsui T., Hamako J., Matsushita T., Nakayama T., Fujimura Y., Titani K. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer. Biochemistry 2002, 41:7939-7946.
47. Mizuno H., Fujimoto Z., Atoda H., Morita T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7230-7234.
48. Mizuno H., Fujimoto Z., Koizumi M., Kano H., Atoda H., Morita T. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region. J. Mol. Biol. 1999, 289:103-112.
49. Momic T., Arlinghaus F.T., Arien-Zakay H., Katzhendler J., Eble J.A., Marcinkiewicz C., Lazarovici P. Pharmacological aspects of viperaxantinapalestinae venom. Toxins (Basel) 2011, 3:1420-1432.
50. Morita T. Structure-function relationships of C-type lectin-related proteins. Pathophysiol. Haemost. Thromb. 2005, 34:156-159.
51. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 2005, 45:1099-1114.
52. Navdaev A., Dormann D., Clemetson J.M., Clemetson K.J. Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction. Blood 2001, 97:2333-2341.
53. Navdaev A., Lochnit G., Eble J.A. The rhodocetin alphabeta subunit targets GPIb and inhibits von Willebrand factor induced platelet activation. Toxicon 2011, 57:1041-1048.
54. Nuyttens B.P., Thijs T., Deckmyn H., Broos K. Platelet adhesion to collagen. Thromb. Res. 2011, 127(Suppl. 2):S26-S29.
55. Ogawa T., Chijiwa T., Oda-Ueda N., Ohno M. Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom. Toxicon 2005, 45:1-14.
56. Okuda D., Horii K., Mizuno H., Morita T. Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. J. Biochem. 2003, 134:19-23.
57. Paaventhan P., Kong C., Joseph J.S., Chung M.C., Kolatkar P.R. Structure of rhodocetin reveals noncovalently bound heterodimer interface. Protein Sci. 2005, 14:169-175.
58. Peng M., Emig F.A., Mao A., Lu W., Kirby E.P., Niewiarowski S., Kowalska M.A. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Thromb. Haemost. 1995, 74:954-957.
59. Peng M., Holt J.C., Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin beta subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem. Biophys. Res. Commun. 1994, 205:68-72.
60. Peng M., Lu W., Beviglia L., Niewiarowski S., Kirby E.P. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993, 81:2321-2328.
61. Peng M., Lu W., Kirby E.P. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 1991, 30:11529-11536.
62. Read M.S., Smith S.V., Lamb M.A., Brinkhous K.M. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989, 74:1031-1035.
63. Rosenow F., Ossig R., Thormeyer D., Gasmann P., Schluter K., Brunner G., Haier J., Eble J.A. Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected]. Neoplasia 2008, 10:168-176.
64. Sekiya F., Atoda H., Morita T. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 1993, 32:6892-6897.
65. Shin Y., Okuyama I., Hasegawa J., Morita T. Molecular cloning of glycoprotein Ib-binding protein, flavocetin-A, which inhibits platelet aggregation. Thromb. Res. 2000, 99:239-247.
66. Staniszewska I., Walsh E.M., Rothman V.L., Gaathon A., Tuszynski G.P., Calvete J.J., Lazarovici P., Marcinkiewicz C. Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis. Cancer Biol. Ther. 2009, 8:1507-1516.
67. Suzuki-Inoue K., Fuller G.L., Garcia A., Eble J.A., Pohlmann S., Inoue O., Gartner T.K., Hughan S.C., Pearce A.C., Laing G.D., Theakston R.D., Schweighoffer E., Zitzmann N., Morita T., Tybulewicz V.L., Ozaki Y., Watson S.P. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006, 107:542-549.
68. Suzuki N., Shikamoto Y., Fujimoto Z., Morita T., Mizuno H. Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2005, 61:147-149.
69. Taniuchi Y., Kawasaki T., Fujimura Y. The high molecular mass, glycoprotein Ib-binding protein flavocetin-A induces only small platelet aggregates in vitro. Thromb. Res. 2000, 97:69-75.
70. Taniuchi Y., Kawasaki T., Fujimura Y., Suzuki M., Titani K., Sakai Y., Kaku S., Hisamichi N., Satoh N., Takenaka T., et al. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim. Biophys. Acta 1995, 1244:331-338.
71. Usami Y., Fujimura Y., Suzuki M., Ozeki Y., Nishio K., Fukui H., Titani K. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:928-932.
72. Usami Y., Suzuki M., Yoshida E., Sakurai Y., Hirano K., Kawasaki T., Fujimura Y., Titani K. Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris. Biochem. Biophys. Res. Commun. 1996, 219:727-733.
73. Wang R., Kini R.M., Chung M.C. Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits. Biochemistry 1999, 38:7584-7593.
74. Watson A.A., O'Callaghan C.A. Molecular analysis of the interaction of the snake venom rhodocytin with the platelet receptor CLEC-2. Toxins (Basel) 2011, 3:991-1003.
75. Yoshida E., Fujimura Y., Miura S., Sugimoto M., Fukui H., Narita N., Usami Y., Suzuki M., Titani K. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem. Biophys. Res. Commun. 1993, 191:1386-1392.